Premium
Role of Platelet‐Activating Factor in Two‐Kidney, One‐Clip Hypertension
Author(s) -
Takahashi Shinichi,
Imagawa Masaharu,
Mimata Hiromitsu,
Nakagawa Masayuki,
Ogata Jiro,
Nomura Yoshio
Publication year - 1997
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/j.1442-2042.1997.tb00213.x
Subject(s) - platelet activating factor , renal medulla , medicine , kidney , medulla , antagonist , endocrinology , renal artery stenosis , renovascular hypertension , renal artery , renal cortex , receptor
Background: Platelet‐activating factor (PAF) is a bioactive phospholipid which is a potent hypotensive agent. To investigate the role of PAF in renovascular hypertension, we determined the PAF concentration and its production level assessed by the activity of cholinephosphotransferase (CPT) in renal tissue and examined the effect of a PAF antagonist on the mean arterial pressure (MAP) in control and two‐kidney with one clipped (2K1C) hypertensive rats. Materials and Methods: The concentration of PAF and CPT in the renal medulla and cortex were determined by radioassay. Also, the effect of a PAF antagonist, CV‐6209, on MAP was also examined in both 2K1C hypertensive and normal control rats. Results: The PAF concentration and CPT activity were significantly higher in the medulla than in the cortex in both 2K1C hypertensive and normal control rats, and both values in the medulla were also significantly higher in the clipped kidney than in the contralateral undipped kidney or in control rat kidneys. We also observed a significant negative correlation between the PAF concentration in the medulla, and the medulla weight in the clipped kidney of 2K1C hypertensive rats. Infusion of the PAF antagonist, CV‐6209, did not affect MAP in 2K1C hypertensive rats, but was significantly increased (P< 0.05) in control rats. Conclusions: These findings suggest that PAF, whose production is induced by renal ischemia due to renal artery stenosis, plays an important role in the renomedullary vasodepressor system, but the effect of PAF as a vasodilator in the peripheral vessels is limited in 2K1C hypertension.